advenchen.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title Advenchen – Welcome to
Description Moorpark, CA, 93021 info@advenchen.com Menu Home Pipeline Alliance News Career Contact Us Welcome to Advenchen! Advenchen Laboratories is a small pharmace
Keywords N/A
Server Information
WebSite advenchen faviconadvenchen.com
Host IP 67.195.197.24
Location United States
Related Websites
Site Rank
More to Explore
advenchen.com Valuation
US$2,750,944
Last updated: 2023-05-10 12:26:25

advenchen.com has Semrush global rank of 3,847,517. advenchen.com has an estimated worth of US$ 2,750,944, based on its estimated Ads revenue. advenchen.com receives approximately 317,417 unique visitors each day. Its web server is located in United States, with IP address 67.195.197.24. According to SiteAdvisor, advenchen.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,750,944
Daily Ads Revenue US$2,540
Monthly Ads Revenue US$76,180
Yearly Ads Revenue US$914,160
Daily Unique Visitors 21,162
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
advenchen.com. A 1200 IP: 67.195.197.24
advenchen.com. NS 86400 NS Record: yns2.yahoo.com.
advenchen.com. NS 86400 NS Record: yns1.yahoo.com.
advenchen.com. MX 1200 MX Record: 10 mx-biz.mail.am0.yahoodns.net.
advenchen.com. TXT 1200 TXT Record: i=192&m=geo-g3-mx2-p9
HtmlToTextCheckTime:2023-05-10 12:26:25
Moorpark, CA, 93021 info@advenchen.com Menu Home Pipeline Alliance News Career Contact Us Welcome to Advenchen! Advenchen Laboratories is a small pharmaceutical company focusing on pharmaceutical research and development involving small molecule cancer drug discovery programs. Our scientists are looking for small molecule kinase inhibitors, especially protein tyrosine kinases (PTK) inhibitors, that target the regulation of various PTK for cancer treatment. Our proprietary drug development product pipeline has demonstrated strong anti-tumor activities and therapeutic benefits in various target scopes. It is believed that our novel small molecules will bring breakthrough and promising therapies as well as a prosperous future for cancer patients. Our crucial capability is to create innovative chemical fragments and scaffolds that may contribute better solubility, pharmacodynamics, pharmacokinetics and toxicology profiles to bring us the most promising preclinical and clinical candidates.
HTTP Headers
HTTP/1.1 200 OK
Date: Tue, 02 Nov 2021 18:41:14 GMT
X-Pingback: http://advenchen.com/xmlrpc.php
Link: ; rel="https://api.w.org/"
Link: ; rel=shortlink
P3P: policyref="https://policies.yahoo.com/w3c/p3p.xml", CP="CAO DSP COR CUR ADM DEV TAI PSA PSD IVAi IVDi CONi TELo OTPi OUR DELi SAMi OTRi UNRi PUBi IND PHY ONL UNI PUR FIN COM NAV INT DEM CNT STA POL HEA PRE LOC GOV"
Cache-Control: private
Content-Type: text/html; charset=UTF-8
Age: 4
Connection: keep-alive
Server: ATS
advenchen.com Whois Information
Domain Name: ADVENCHEN.COM
Registry Domain ID: 1166103352_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucows.com
Updated Date: 2021-07-22T05:08:19Z
Creation Date: 2007-08-20T00:28:38Z
Registry Expiry Date: 2022-08-20T00:28:38Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: YNS1.YAHOO.COM
Name Server: YNS2.YAHOO.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-23T08:53:19Z <<<